Latest News about AZN
Recent news which mentions AZN
Why Is Icosavax (ICVX) Stock Up 46% Today?
December 12, 2023
From InvestorPlace
From InvestorPlace
From MarketWatch
From Benzinga
From Benzinga
AstraZeneca's Investigational Drug Shows Durable Clinical Benefit In Patients With Rare Blood Disease
December 11, 2023
Tickers
AZN
From Benzinga
Tickers
AZN
From Motley Fool
From MarketWatch
From Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
From Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
From Benzinga
AstraZeneca Stops Two Lokelma Late-Stage Trials After Evaluating Potential Benefits
December 01, 2023
Tickers
AZN
From Benzinga
Industry Comparison: Evaluating AstraZeneca Against Competitors In Pharmaceuticals Industry
November 27, 2023
Tickers
AZN
From Benzinga
Eli Lilly and Novo Nordisk Are Big Names in Weight Loss, but Investors Shouldn't Count Out This Healthcare Giant
November 22, 2023
Tickers
AZN
From Motley Fool
3 No-Brainer Stocks to Buy With $1,000 Right Now
November 22, 2023
From Motley Fool
5 Growth Stocks to Buy for 2024
November 20, 2023
From InvestorPlace
US CDC Rolls Out Additional Doses For Sanofi/AstraZeneca Recently Approved Respiratory Infection Drug As Demand Surges
November 17, 2023
From Benzinga
AstraZeneca Is Trying to Make an Ozempic Competitor (Again), but Don't Rush to Buy the Stock
November 17, 2023
From Motley Fool
FDA Approves AstraZeneca's Truqap/Faslodex Combo Therapy For Breast Cancer, Competes With Gilead's Drug
November 17, 2023
From Benzinga
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
From Benzinga
AstraZeneca's Flagship Cancer Drug Imfinzi Fails On Main Goal In Lung Cancer Trial When Combined With Chemoradiotherapy
November 14, 2023
Tickers
AZN
From Benzinga
Royal Rule: Buy These 3 Dividend Aristocrats on Every. Single. Dip.
November 13, 2023
From InvestorPlace
Investigating AstraZeneca's Standing In Pharmaceuticals Industry Compared To Competitors
November 13, 2023
Tickers
AZN
From Benzinga
Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
November 10, 2023
From MarketWatch
Tags
NASDAQ:AAPL,NYSE:LMT,NYSE:CVX,NASDAQ:LI,NYSE:CRM,NASDAQ:AZN,NASDAQ:COST,NYSE:RIO
CRM
Stocks to Buy
From InvestorPlace
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
November 09, 2023
Tickers
AZN
From Motley Fool
AstraZeneca Joins Anti-Obesity Race Dominated By Eli Lilly And Novo Nordisk, Reports Mixed Q3 Earnings
November 09, 2023
Tickers
AZN
From Benzinga
Wall Street To Snap Longest Winning Streak Since 2021 Today? Earnings, Bond Yields In Focus Ahead Of Powell's Speech
November 09, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.